REPORT HIGHLIGHT
The botulinum toxin market is estimated to represent a global market of USD 4.72 billion by 2019 with growth rate of 8.2%.

Botulinum toxin (also termed as miracle poison) is a type of poisonous biological substance, neurotoxic protein, produced by bacterium Clostridium botulinum species. This species is a gram-positive, spore-forming, anaerobic rod commonly found in soil, plants & in water. Botulinum toxin acts by interfering with neural transmission and blocks the release of acetylcholine which may cause muscle paralysis. This drug is injected into a patient using a 30-gauge 1-inch needle to the affected muscles.

Market Dynamics
Growing demand for minimally invasive treatment coupled with increasing therapeutic use of this toxin is further driving the market growth. For example, nowadays, botulinum toxins play a very important role in the management of medical conditions such as focal dystonias, hyperhidrosis, hypersalivation, headaches, and hemi-facial spasm. Additionally, the list of possible use of this protein as therapeutic in various disease condition is rapidly expanding which will provide significant growth opportunities for this market to grow. However, high side effects and lack of reimbursement coverage for this treatment hampers the market growth to some extent. For example, most procedures are intended for an aesthetic purpose such as to reduce fat and wrinkles which are not covered by reimbursement policies.

COVID-19 Impact and Recovery Analysis
This is a latest botulinum toxin market report, covering the current COVID-19 impact on the market. The pandemic has affected every aspect of life globally. This outbreak has brought along several changes in botulinum toxin market conditions. The rapidly changing market scenario and initial and future assessment of the COVID impact is covered in the published botulinum toxin report. It covers the entire study with an in-depth analysis on revenue growth and possible growth prospect in future. The report also delivers on key players along with strategic standpoint pertaining to price and promotions.

Regional Takeaway
Regionally, North America accounted for the 36.23% share of the global market in 2019. Growing demand for this treatment for aesthetic appearance coupled with increasing disposable income drives the regional growth. Whereas, Europe is projected to capture more than 26% share of the overall industry by 2021-2027. Availability of effective botulinum treatments augments the growth in this region. For example, Dysport, the type A product available in Europe and is widely distributed in 500-unit vials which can be stored at room temperature. Trailed closely by the Asia Pacific, this region is expected to grow with a significant growth rate over the study period. Growing medical tourism industry coupled with increasing geriatric population is anticipated to support the growth. For example, according to the World Bank, more than 25.0% of the Japanese population is over 65 years of age.

Key Vendor Takeaway
Companies namely Allergan, Ipsen Group, Medytox, and Metabiologics are some of the key companies operating in this market. Growing research and activities in collaboration with government organizations helped these companies to attain the notable market position. For instance, in May 2016, Ipsen signed a partnership agreement with the Institute of Molecular and Cell Biology (IMCB) for the study of intracellular trafficking of the Botulinum neurotoxins in the neurons. The partnership is expected to help both the companies expand applications of botulinum toxins.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year 2016 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BOTULINUM TOXIN MARKET, BY PRODUCT
Type A
Dysport
Xeomin
Botox
Other
Type B
Myobloc
Others

GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION
Therapeutic
Cosmetic

GLOBAL BOTULINUM TOXIN MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America